微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11.39% | 709.09% | 131.72% | 1/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -35.91% | 38.33% | -656% | 141/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -4.75% | 68.5% | 39.87% | 131/159 | 4.18% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -7.9% | 5.95% | -322.46% | 137/159 | 2.63% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -1.87% | -228.97% | 96.79% | 131/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -58.23% | -166.13% | -286.14% | 146/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -15.08% | -59.07% | -79.52% | 139/159 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -8.4% | -339.79% | -679.31% | 136/159 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.45% | 139.62% | 106.63% | 75/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -21.88% | 10.88% | -130.8% | 136/159 | 0.74% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -9.48% | -27.08% | -396.34% | 129/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -1.91% | 48.38% | 47.81% | 124/159 | 2.22% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -3.66% | -357.75% | 85.09% | 131/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -24.55% | 24.6% | -229.09% | 137/159 | 0.87% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -7.46% | -400.81% | -101.62% | 125/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -3.7% | -309.04% | -360.56% | 126/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.42% | 42% | 104.36% | 83/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -32.56% | 0.7% | -1412.9% | 138/159 | 3.71% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.48% | 149.4% | 40.11% | 91/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.77% | -8.29% | 77% | 93/159 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1% | -34.64% | 103.05% | 69/159 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -32.79% | -231.88% | -553.19% | 129/159 | 2.71% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | -5.02% | -167.56% | -360.1% | 104/159 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1.93% | -61.63% | 26.14% | 88/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.53% | -39.04% | 115.49% | 67/159 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -9.88% | -216.51% | -232.97% | 126/159 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 7.43% | 17.01% | 47.71% | 43/159 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.03% | 18.35% | 100.4% | 41/159 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.51% | 16.74% | -70.4% | 42/159 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.48% | -5.25% | 33.54% | 60/159 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 6.35% | -24.22% | 49.41% | 52/159 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.25% | 6.78% | 97.67% | 57/159 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.15% | -0.46% | -75.98% | 40/159 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 8.95% | -27.82% | 6.8% | 64/159 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 8.38% | 15.91% | 110.55% | 33/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 3.98% | 6.13% | 84.26% | 49/159 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.16% | 18.03% | -82.58% | 37/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 12.4% | -11.24% | 71.51% | 42/159 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 7.23% | -17.37% | 92.8% | 36/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 3.75% | -9.86% | 104.92% | 49/159 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.83% | 0.55% | -86.9% | 43/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |